Profil
Ms. Rose Weldon is a Senior VP-Corporate Affairs & Head-Media at Cullinan Therapeutics, Inc. Ms. Weldon was previously employed as a Vice President-Communications by Cullinan Oncology LLC, a Head-Communications by Bristol Myers Squibb Co., a Manager-Internal Communications by Sanofi-Aventis U.S.
LLC, a Chief Financial Officer by Amylyx Pharmaceuticals, Inc., and a Vice President by Bluerock Therapeutics, Inc. She received her undergraduate degree from Saint Joseph's University and a graduate degree from LaSalle University.
Postes actifs de Rose Weldon
| Sociétés | Poste | Début |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Public Communications Contact | 01/02/2022 |
Anciens postes connus de Rose Weldon
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Public Communications Contact | 01/02/2022 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Public Communications Contact | 01/04/2010 |
Bluerock Therapeutics, Inc.
Bluerock Therapeutics, Inc. BlueRock Therapeutics is a clinical stage cell therapy company that aims to transform the treatment of degenerative diseases through cell therapy. The company, a wholly-owned subsidiary of Bayer AG, operates as a cornerstone of its Cell & Gene Therapy Platform. BlueRock's mission is to discover and develop cell therapies that can change the way diseases are treated and improve the lives of patients. The team is committed to realizing the potential of regenerative medicine to help patients suffering from disease by developing new and impactful cellular therapies. BlueRock is based in New York. | Corporate Officer/Principal | - |
| AMYLYX PHARMACEUTICALS, INC. | Directeur Financier/CFO | - |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Public Communications Contact | - |
Formation de Rose Weldon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
LaSalle University
LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
Cullinan Oncology, Inc.
Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bluerock Therapeutics, Inc.
Bluerock Therapeutics, Inc. BlueRock Therapeutics is a clinical stage cell therapy company that aims to transform the treatment of degenerative diseases through cell therapy. The company, a wholly-owned subsidiary of Bayer AG, operates as a cornerstone of its Cell & Gene Therapy Platform. BlueRock's mission is to discover and develop cell therapies that can change the way diseases are treated and improve the lives of patients. The team is committed to realizing the potential of regenerative medicine to help patients suffering from disease by developing new and impactful cellular therapies. BlueRock is based in New York. | |
Saint Joseph's University
Saint Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















